143 related articles for article (PubMed ID: 32268533)
1. Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention.
Takahashi N; Dohi T; Endo H; Funamizu T; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268533
[TBL] [Abstract][Full Text] [Related]
2. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
[TBL] [Abstract][Full Text] [Related]
3. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
[TBL] [Abstract][Full Text] [Related]
4. Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention.
Ahn JH; Tantry US; Kang MG; Park HW; Koh JS; Bae JS; Cho SY; Kim KH; Jang JY; Park JR; Park Y; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
JACC Asia; 2022 Jun; 2(3):323-337. PubMed ID: 36338415
[TBL] [Abstract][Full Text] [Related]
5. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
Kalkman DN; Aquino M; Claessen BE; Baber U; Guedeney P; Sorrentino S; Vogel B; de Winter RJ; Sweeny J; Kovacic JC; Shah S; Vijay P; Barman N; Kini A; Sharma S; Dangas GD; Mehran R
Eur Heart J; 2018 Dec; 39(46):4101-4108. PubMed ID: 30358832
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
7. Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
Circ J; 2016 Dec; 81(1):90-95. PubMed ID: 27867158
[TBL] [Abstract][Full Text] [Related]
8. Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosis.
Yu Y; Lou Y; Pan Y; Yan L; Fu W; Hou Z; Cui R; Miao Z; Wang Y; Lou X; Ma N
Stroke Vasc Neurol; 2023 Aug; ():. PubMed ID: 37640497
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention.
Endo H; Dohi T; Funamizu T; Shitara J; Wada H; Doi S; Naito R; Konishi H; Ogita M; Iwata H; Kasai T; Okazaki S; Isoda K; Shimada K; Miyauchi K; Daida H
Circ J; 2019 Feb; 83(3):630-636. PubMed ID: 30541988
[TBL] [Abstract][Full Text] [Related]
10. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Circ J; 2017 Aug; 81(9):1293-1300. PubMed ID: 28428450
[TBL] [Abstract][Full Text] [Related]
11. Baseline High-Sensitivity C-Reactive Protein as a Predictor of Adverse Clinical Events in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
Yang S; Pan Y; Zheng W
Cardiol Rev; 2023 Sep; ():. PubMed ID: 37754679
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
[TBL] [Abstract][Full Text] [Related]
14. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention].
Chen RZ; Liu C; Zhou P; Tan Y; Sheng ZX; Li JN; Zhou JY; Wu Y; Yang YM; Song L; Zhao HJ; Yan HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):359-366. PubMed ID: 32450651
[No Abstract] [Full Text] [Related]
15. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
[TBL] [Abstract][Full Text] [Related]
16. Baseline high-sensitivity C-reactive protein and glycosylated hemoglobinA1c predict adverse outcomes in patients with chronic coronary syndromes undergoing percutaneous coronary intervention.
Tang XF; Yuan DS; Zhu P; Xu N; Yao Y; Wang PZ; Chen Y; Gao LJ; Song L; Yang YJ; Gao RL; Zhao XY; Yuan JQ
Heliyon; 2024 Jan; 10(1):e23900. PubMed ID: 38192767
[TBL] [Abstract][Full Text] [Related]
17. Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
Klingenberg R; Aghlmandi S; Gencer B; Nanchen D; Räber L; Carballo D; Carballo S; Stähli BE; Landmesser U; Rodondi N; Mach F; Windecker S; Bucher HC; von Eckardstein A; Lüscher TF; Matter CM
Atherosclerosis; 2021 Mar; 320():31-37. PubMed ID: 33524907
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
[TBL] [Abstract][Full Text] [Related]
19. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
[TBL] [Abstract][Full Text] [Related]
20. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
